{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T01:45:30Z","timestamp":1777081530984,"version":"3.51.4"},"reference-count":53,"publisher":"Japan Neurosurgical Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol. Med. Chir.(Tokyo)"],"published-print":{"date-parts":[[2013]]},"DOI":"10.2176\/nmc.ra2013-0256","type":"journal-article","created":{"date-parts":[[2013,10,28]],"date-time":"2013-10-28T23:02:03Z","timestamp":1383001323000},"page":"773-778","source":"Crossref","is-referenced-by-count":22,"title":["Usefulness of FMISO\u2014PET for Glioma Analysis"],"prefix":"10.2176","volume":"53","author":[{"given":"Hiroyuki","family":"KOBAYASHI","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Graduate School of Medicine, Hokkaido University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"HIRATA","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Graduate School of Medicine, Hokkaido University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"YAMAGUCHI","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Graduate School of Medicine, Hokkaido University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"TERASAKA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Graduate School of Medicine, Hokkaido University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"SHIGA","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Graduate School of Medicine, Hokkaido University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyohiro","family":"HOUKIN","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Graduate School of Medicine, Hokkaido University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"971","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Alavi JB, Alavi A, Chawluk J, Kushner M, Powe J, Hickey W, Reivich M: Positron emission tomography in patients with glioma. A predictor of prognosis. <i>Cancer<\/i> 62: 1074\u20131078, 1988","DOI":"10.1002\/1097-0142(19880915)62:6<1074::AID-CNCR2820620609>3.0.CO;2-H"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Bayer C, Shi K, Astner ST, Maftei CA, Vaupel P: Acute versus chronic hypoxia: why a simplified classification is simply not enough. <i>Int J Radiat Oncol Biol Phys<\/i> 80: 965\u2013968, 2011","DOI":"10.1016\/j.ijrobp.2011.02.049"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) B\u00e9nard F, Romsa J, Hustinx R: Imaging gliomas with positron emission tomography and single-photon emission computed tomography. <i>Semin Nucl Med<\/i> 33: 148\u2013162, 2003","DOI":"10.1053\/snuc.2003.127304"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Borb\u00e9ly K, Ny\u00e1ry I, T\u00f3th M, Ericson K, Guly\u00e1s B: Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas. <i>J Neurol Sci<\/i> 246: 85\u201394, 2006","DOI":"10.1016\/j.jns.2006.02.015"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Braun V, Dempf S, Weller R, Reske SN, Schachenmayr W, Richter HP: Cranial neuronavigation with direct integration of (11)C methionine positron emission tomography (PET) data\u2014results of a pilot study in 32 surgical cases. <i>Acta Neurochir (Wien)<\/i> 144: 777\u2013782; discussion 782, 2002","DOI":"10.1007\/s00701-002-0942-5"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Chapman JD, Franko AJ, Sharplin J: A marker for hypoxic cells in tumours with potential clinical applicability. <i>Br J Cancer<\/i> 43: 546\u2013550, 1981","DOI":"10.1038\/bjc.1981.79"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Chen W: Clinical applications of PET in brain tumors. <i>J Nucl Med<\/i> 48: 1468\u20131481, 2007","DOI":"10.2967\/jnumed.106.037689"},{"key":"8","unstructured":"8) Cher LM, Murone C, Lawrentschuk N, Ramdave S, Papenfuss A, Hannah A, O\u2019Keefe GJ, Sachinidis JI, Berlangieri SU, Fabinyi G, Scott AM: Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies. <i>J Nucl Med<\/i> 47: 410\u2013418, 2006"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Collingridge DR, Piepmeier JM, Rockwell S, Knisely JP: Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue. <i>Radiother Oncol<\/i> 53: 127\u2013131, 1999","DOI":"10.1016\/S0167-8140(99)00121-8"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) De Witte O, Goldberg I, Wikler D, Rorive S, Damhaut P, Monclus M, Salmon I, Brotchi J, Goldman S: Positron emission tomography with injection of methionine as a prognostic factor in glioma. <i>J Neurosurg<\/i> 95: 746\u2013750, 2001","DOI":"10.3171\/jns.2001.95.5.0746"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Delbeke D, Meyerowitz C, Lapidus RL, Maciunas RJ, Jennings MT, Moots PL, Kessler RM: Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. <i>Radiology<\/i> 195: 47\u201352, 1995","DOI":"10.1148\/radiology.195.1.7892494"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Dence CS, Ponde DE, Welch MJ, Lewis JS: Autoradiographic and small-animal PET comparisons between (18)F-FMISO, (18)F-FDG, (18)F-FLT and the hypoxic selective (64)Cu-ATSM in a rodent model of cancer. <i>Nucl Med Biol<\/i> 35: 713\u2013720, 2008","DOI":"10.1016\/j.nucmedbio.2008.06.001"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Evans SM, Jenkins KW, Jenkins WT, Dilling T, Judy KD, Schrlau A, Judkins A, Hahn SM, Koch CJ: Imaging and analytical methods as applied to the evaluation of vasculature and hypoxia in human brain tumors. <i>Radiat Res<\/i> 170: 677\u2013690, 2008","DOI":"10.1667\/RR1207.1"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Evans SM, Judy KD, Dunphy I, Jenkins WT, Hwang WT, Nelson PT, Lustig RA, Jenkins K, Magarelli DP, Hahn SM, Collins RA, Grady MS, Koch CJ: Hypoxia is important in the biology and aggression of human glial brain tumors. <i>Clin Cancer Res<\/i> 10: 8177\u20138184, 2004","DOI":"10.1158\/1078-0432.CCR-04-1081"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Goldman S, Levivier M, Pirotte B, Brucher JM, Wikler D, Damhaut P, Stanus E, Brotchi J, Hildebrand J: Regional glucose metabolism and histopathology of gliomas. A study based on positron emission tomography-guided stereotactic biopsy. <i>Cancer<\/i> 78: 1098\u20131106, 1996","DOI":"10.1002\/(SICI)1097-0142(19960901)78:5<1098::AID-CNCR21>3.3.CO;2-A"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Herholz K, H\u00f6lzer T, Bauer B, Schr\u00f6der R, Voges J, Ernestus RI, Mendoza G, Weber-Luxenburger G, L\u00f6ttgen J, Thiel A, Wienhard K, Heiss WD: 11C-methionine PET for differential diagnosis of low-grade gliomas. <i>Neurology<\/i> 50: 1316\u20131322, 1998","DOI":"10.1212\/WNL.50.5.1316"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Hirata K, Terasaka S, Shiga T, Hattori N, Magota K, Kobayashi H, Yamaguchi S, Houkin K, Tanaka S, Kuge Y, Tamaki N: <sup>18<\/sup>F-Fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas. <i>Eur J Nucl Med Mol Imaging<\/i> 39: 760\u2013770, 2012","DOI":"10.1007\/s00259-011-2037-0"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Jerabek PA, Patrick TB, Kilbourn MR, Dischino DD, Welch MJ: Synthesis and biodistribution of 18F-labeled fluoronitroimidazoles: potential in vivo markers of hypoxic tissue. <i>Int J Rad Appl Instrum A<\/i> 37: 599\u2013605, 1986","DOI":"10.1016\/0883-2889(86)90079-1"},{"key":"19","unstructured":"19) Kaschten B, Stevenaert A, Sadzot B, Deprez M, Degueldre C, Del Fiore G, Luxen A, Reznik M: Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and\/or carbon-11-methionine. <i>J Nucl Med<\/i> 39: 778\u2013785, 1998"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Kato T, Shinoda J, Oka N, Miwa K, Nakayama N, Yano H, Maruyama T, Muragaki Y, Iwama T: Analysis of 11C-methionine uptake in low-grade gliomas and correlation with proliferative activity. <i>AJNR Am J Neuroradiol<\/i> 29: 1867\u20131871, 2008","DOI":"10.3174\/ajnr.A1242"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Kim S, Chung JK, Im SH, Jeong JM, Lee DS, Kim DG, Jung HW, Lee MC: 11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET. <i>Eur J Nucl Med Mol Imaging<\/i> 32: 52\u201359, 2005","DOI":"10.1007\/s00259-004-1598-6"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Koch CJ, Evans SM: Non-invasive PET and SPECT imaging of tissue hypoxia using isotopically labeled 2-nitroimidazoles. <i>Adv Exp Med Biol<\/i> 510: 285\u2013292, 2003","DOI":"10.1007\/978-1-4615-0205-0_47"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Koch CJ, Shuman AL, Jenkins WT, Kachur AV, Karp JS, Freifelder R, Dolbier WR, Evans SM: The radiation response of cells from 9L gliosarcoma tumours is correlated with [F18]-EF5 uptake. <i>Int J Radiat Biol<\/i> 85: 1137\u20131147, 2009","DOI":"10.3109\/09553000903242172"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Kracht LW, Miletic H, Busch S, Jacobs AH, Voges J, Hoevels M, Klein JC, Herholz K, Heiss WD: Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology. <i>Clin Cancer Res<\/i> 10: 7163\u20137170, 2004","DOI":"10.1158\/1078-0432.CCR-04-0262"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Kurihara H, Honda N, Kono Y, Arai Y: Radiolabelled agents for PET imaging of tumor hypoxia. <i>Curr Med Chem<\/i> 19: 3282\u20133289, 2012","DOI":"10.2174\/092986712801215964"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Lally BE, Rockwell S, Fischer DB, Collingridge DR, Piepmeier JM, Knisely JP: The interactions of polarographic measurements of oxygen tension and histological grade in human glioma. <i>Cancer J<\/i> 12: 461\u2013466, 2006","DOI":"10.1097\/00130404-200611000-00005"},{"key":"27","unstructured":"27) Langen KJ, M\u00fchlensiepen H, Holschbach M, Hautzel H, Jansen P, Coenen HH: Transport mechanisms of 3-[123I]iodo-alpha-methyl-L-tyrosine in a human glioma cell line: comparison with [3H]methyl]-L-methionine. <i>J Nucl Med<\/i> 41: 1250\u20131255, 2000"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Lee ST, Scott AM: Hypoxia positron emission tomography imaging with 18f-fluoromisonidazole. <i>Semin Nucl Med<\/i> 37: 451\u2013461, 2007","DOI":"10.1053\/j.semnuclmed.2007.07.001"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P: The 2007 WHO classification of tumours of the central nervous system. <i>Acta Neuropathol<\/i> 114: 97\u2013109, 2007","DOI":"10.1007\/s00401-007-0243-4"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Mundinger F, Hahn K: Direct measurements of the partial oxygen tension in different cortical and subcortical structures of the brain and in gliomas during stereotactic operation. <i>Confin Neurol<\/i> 34: 106\u201311, 1972","DOI":"10.1159\/000103041"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Narita T, Aoyama H, Hirata K, Onodera S, Shiga T, Kobayashi H, Murata J, Terasaka S, Tanaka S, Houkin K: Reoxygenation of glioblastoma multiforme treated with fractionated radiotherapy concomitant with temozolomide: changes defined by 18F-fluoromisonidazole positron emission tomography: two case reports. <i>Jpn J Clin Oncol<\/i> 42: 120\u2013123, 2012","DOI":"10.1093\/jjco\/hyr181"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Nehmeh SA, Lee NY, Schr\u00f6der H, Squire O, Zanzonico PB, Erdi YE, Greco C, Mageras G, Pham HS, Larson SM, Ling CC, Humm JL: Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer. <i>Int J Radiat Oncol Biol Phys<\/i> 70: 235\u2013242, 2008","DOI":"10.1016\/j.ijrobp.2007.08.036"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Nojiri T, Nariai T, Aoyagi M, Senda M, Ishii K, Ishiwata K, Ohno K: Contributions of biological tumor parameters to the incorporation rate of L: -[methyl-(11)C] methionine into astrocytomas and oligodendrogliomas. <i>J Neurooncol<\/i> 93: 233\u2013241, 2009","DOI":"10.1007\/s11060-008-9767-2"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) O\u2019Donoghue JA, Zanzonico P, Pugachev A, Wen B, Smith-Jones P, Cai S, Burnazi E, Finn RD, Burgman P, Ruan S, Lewis JS, Welch MJ, Ling CC, Humm JL: Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models. <i>Int J Radiat Oncol Biol Phys<\/i> 61: 1493\u20131502, 2005","DOI":"10.1016\/j.ijrobp.2004.12.057"},{"key":"35","unstructured":"35) Ogawa T, Inugami A, Hatazawa J, Kanno I, Murakami M, Yasui N, Mineura K, Uemura K: Clinical positron emission tomography for brain tumors: comparison of fludeoxyglucose F 18 and L-methyl-11C-methionine. <i>AJNR Am J Neuroradiol<\/i> 17: 345\u2013353, 1996"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Okamoto S, Shiga T, Yasuda K, Ito YM, Magota K, Kasai K, Kuge Y, Shirato H, Tamaki N: High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer. <i>J Nucl Med<\/i> 54: 201\u2013207, 2013","DOI":"10.2967\/jnumed.112.109330"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Padma MV, Said S, Jacobs M, Hwang DR, Dunigan K, Satter M, Christian B, Ruppert J, Bernstein T, Kraus G, Mantil JC: Prediction of pathology and survival by FDG PET in gliomas. <i>J Neurooncol<\/i> 64: 227\u2013237, 2003","DOI":"10.1023\/A:1025665820001"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Paulus W, Peiffer J: Intratumoral histologic heterogeneity of gliomas. A quantitative study. <i>Cancer<\/i> 64: 442\u2013447, 1989","DOI":"10.1002\/1097-0142(19890715)64:2<442::AID-CNCR2820640217>3.0.CO;2-S"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Pirotte B, Goldman S, Dewitte O, Massager N, Wikler D, Lefranc F, Ben Taib NO, Rorive S, David P, Brotchi J, Levivier M: Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures. <i>J Neurosurg<\/i> 104: 238\u2013253, 2006","DOI":"10.3171\/jns.2006.104.2.238"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Postema EJ, McEwan AJ, Riauka TA, Kumar P, Richmond DA, Abrams DN, Wiebe LI: Initial results of hypoxia imaging using 1-alpha-D: -(5-deoxy-5-[18F]-fluoroarabinofuranosyl)-2-nitroimidazole (18F-FAZA). <i>Eur J Nucl Med Mol Imaging<\/i> 36: 1565\u20131573, 2009","DOI":"10.1007\/s00259-009-1154-5"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Rasey JS, Nelson NJ, Chin L, Evans ML, Grunbaum Z: Characteristics of the binding of labeled fluoromisonidazole in cells in vitro. <i>Radiat Res<\/i> 122: 301\u2013308, 1990","DOI":"10.2307\/3577760"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Ribom D, Eriksson A, Hartman M, Engler H, Nilsson A, L\u00e5ngstr\u00f6m B, Bolander H, Bergstr\u00f6m M, Smits A: Positron emission tomography (11)C-methionine and survival in patients with low-grade gliomas. <i>Cancer<\/i> 92: 1541\u20131549, 2001","DOI":"10.1002\/1097-0142(20010915)92:6<1541::AID-CNCR1480>3.0.CO;2-D"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Singhal T, Narayanan TK, Jacobs MP, Bal C, Mantil JC: 11C-methionine PET for grading and prognostication in gliomas: a comparison study with 18F-FDG PET and contrast enhancement on MRI. <i>J Nucl Med<\/i> 53: 1709\u20131715, 2012","DOI":"10.2967\/jnumed.111.102533"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Sorger D, Patt M, Kumar P, Wiebe LI, Barthel H, Seese A, Dannenberg C, Tannapfel A, Kluge R, Sabri O: [18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors. <i>Nucl Med Biol<\/i> 30: 317\u2013326, 2003","DOI":"10.1016\/S0969-8051(02)00442-0"},{"key":"45","unstructured":"45) Spence AM, Muzi M, Mankoff DA, O\u2019Sullivan SF, Link JM, Lewellen TK, Lewellen B, Pham P, Minoshima S, Swanson K, Krohn KA: 18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter. <i>J Nucl Med<\/i> 45: 1653\u20131659, 2004"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Spence AM, Muzi M, Swanson KR, O\u2019Sullivan F, Rockhill JK, Rajendran JG, Adamsen TC, Link JM, Swanson PE, Yagle KJ, Rostomily RC, Silbergeld DL, Krohn KA: Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival. <i>Clin Cancer Res<\/i> 14: 2623\u20132630, 2008","DOI":"10.1158\/1078-0432.CCR-07-4995"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Swanson KR, Chakraborty G, Wang CH, Rockne R, Harpold HL, Muzi M, Adamsen TC, Krohn KA, Spence AM: Complementary but distinct roles for MRI and 18F-fluoromisonidazole PET in the assessment of human glioblastomas. <i>J Nucl Med<\/i> 50: 36\u201344, 2009","DOI":"10.2967\/jnumed.108.055467"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Tateishi K, Tateishi U, Sato M, Yamanaka S, Kanno H, Murata H, Inoue T, Kawahara N: Application of 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET imaging to predict highly malignant tumor grades and hypoxia-inducible factor-1\u03b1 expression in patients with glioma. <i>AJNR Am J Neuroradiol<\/i> 34: 92\u201399, 2013","DOI":"10.3174\/ajnr.A3159"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Thorwarth D, Eschmann SM, Paulsen F, Alber M: A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxia. <i>Phys Med Biol<\/i> 50: 2209\u20132224, 2005","DOI":"10.1088\/0031-9155\/50\/10\/002"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Tovi M, Lilja A, Bergstr\u00f6m M, Ericsson A, Bergstr\u00f6m K, Hartman M: Delineation of gliomas with magnetic resonance imaging using Gd-DTPA in comparison with computed tomography and positron emission tomography. <i>Acta Radiol<\/i> 31: 417\u2013429, 1990","DOI":"10.1080\/02841859009173067"},{"key":"51","unstructured":"51) Valk PE, Mathis CA, Prados MD, Gilbert JC, Budinger TF: Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoromisonidazole. <i>J Nucl Med<\/i> 33: 2133\u20132137, 1992"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Yamamoto Y, Maeda Y, Kawai N, Kudomi N, Aga F, Ono Y, Nishiyama Y: Hypoxia assessed by 18F-fluoromisonidazole positron emission tomography in newly diagnosed gliomas. <i>Nucl Med Commun<\/i> 33: 621\u2013625, 2012","DOI":"10.1097\/MNM.0b013e3283529984"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Ziemer LS, Evans SM, Kachur AV, Shuman AL, Cardi CA, Jenkins WT, Karp JS, Alavi A, Dolbier WR, Koch CJ: Noninvasive imaging of tumor hypoxia in rats using the 2-nitroimidazole 18F-EF5. <i>Eur J Nucl Med Mol Imaging<\/i> 30: 259\u2013266, 2003","DOI":"10.1007\/s00259-002-1037-5"}],"container-title":["Neurologia medico-chirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/53\/11\/53_ra2013-0256\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T04:24:34Z","timestamp":1621484674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/53\/11\/53_ra2013-0256\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.2176\/nmc.ra2013-0256","relation":{},"ISSN":["0470-8105","1349-8029"],"issn-type":[{"value":"0470-8105","type":"print"},{"value":"1349-8029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}